<p>The present invention is directed to novel kinase inhibitors of general formula (I) and pharmaceutically acceptable salts thereof, and to the use of the kinase inhibitors of general formula (I) for treating diseases or disorders in which tau phosphorylation and cell cycle regulation is implicated, such as Alzheimer's Disease and cancer.</p>
申请公布号
WO2011049722(A1)
申请公布日期
2011.04.28
申请号
WO2010US50689
申请日期
2010.09.29
申请人
MERCK SHARP & DOHME CORP.;SIU, TONY;DINSMORE, CHRISTOPHER;KUMARASINGHE, SATHYAJITH, E.
发明人
SIU, TONY;DINSMORE, CHRISTOPHER;KUMARASINGHE, SATHYAJITH, E.